Julie Barnes, PhD.
Julie has over 30 years experience of the Pharmaceutical and Biotechnology industry. She trained in pharmacology and neuroscience and gained 15 years experience in R&D with GlaxoSmithKline, latterly as head of Neuroscience. From 2001-2009, she was Chief Scientific Officer / Board Director at BioWisdom Ltd, a healthcare technology company providing innovative data solutions for the pharmaceutical industry. Julie has a deep understanding of the healthcare sector, both pharmaceutical R&D, diagnostics and other emerging solutions for better health management. She has spearheaded specific initiatives, including the development of medical imaging techniques for use in early clinical trials, assessment of safety liability in pharmaceutical products, creation of novel informatics solutions to support R&D, and delivered innovative diagnostic solutions for better healthcare. In 2013, she won the WISE (Women in Science and Engineering) Award for Enterprise and Innovation award by HRH The Princess Royal.
Chris has over 20 years’ experience in finance and has held senior positions at a variety of organization types, ranging from business start-ups to a FTSE 250 company. He joined Abcodia as CFO in October 2015. Before joining the company Chris was CFO at Zinwave Ltd, steering the company to its sale in 2014. He was the Finance Director at Enecsys Ltd. and played a fundamental role in numerous fund raising activities, (including Series B for $41m) to support the global growth of the organization.
Kate has over 25 years of life science experience working in both the public and private healthcare sectors. For the last 8 years she has worked specifically in investment; leading investments and serving on the boards of early stage companies in the life sciences and med tech sectors. Kate has held a diverse number of roles from initiating and growing start up diagnostics companies to leading Business Development in Europe for a multinational business. Much of Kate’s time has been spent driving commercial activities and developing commercial strategies in order to grow businesses.